Found 2068 clinical trials
A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia
This study is a randomized, double-blind, placebo-controlled study of the safety, tolerability, and efficacy of SAGE-217 compared to placebo in adult subjects with comorbid major depressive
- 280 views
- 27 Jun, 2019
- 2 locations
A Research Study is being conducted to evaluate an investigational product to be used for the treatment of Major Depressive Disorder (or MDD) in women. Qualified participants receive study-related care, and exams at no charge.
A Research Study is being conducted to evaluate an investigational product to be used for the treatment of Major Depressive Disorder (or MDD) in women. Qualified participants receive study-related
- 948 views
- 08 Nov, 2020
- 1 location
Study of Efficacy of PEAR-004 in Schizophrenia.
The purpose of the study is to determine in patients currently being administered antipsychotic pharmacotherapy whether PEAR-004 can further reduce symptoms of schizophrenia as measured by the Positive and Negative Syndrome Scale (PANSS). The overall rationale for the study is to assess the first prescription digital therapeutic (PDT) in schizophrenia …
- 50 views
- 22 Dec, 2020
- 1 location
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics.
This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable schizophrenia participants treated with antipsychotics.
- 45 views
- 22 Dec, 2020
- 1 location
Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia (RISE).
The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously as compared to placebo during maintenance treatment in adult and adolescent patients with schizophrenia. The study will include male and female patients, 13 to 65 years of age, who …
- 73 views
- 22 Dec, 2020
- 1 location
Clinical trial measuring efficacy of Vortioxetine for relapse prevention in adults with MDD
Clinical trial measuring efficacy of Vortioxetine for relapse prevention in adults with MDD
- 100 views
- 23 Nov, 2020
- 1 location